Reports
Reports
The global ophthalmic diagnostic devices market size attained a value of nearly USD 5.25 billion in 2022. The market is further expected to grow at a CAGR of 4.90% during the forecast period of 2023-2028 to attain a market value of about USD 7 billion by 2028.
An ophthalmic diagnostic device a device that helps in surgery, diagnosis, and vision correction. It is used in the diagnosis of optometry and ophthalmology. Optometry is a specific healthcare profession that includes analysing the eyes, along with other related structures for abnormalities or defects. Ophthalmology is known as a specialised study of medical conditions related to the eye.
Moreover, innovative technology platforms provide accuracy, and enhanced imaging reliability, along with safety and minimal post-operative pain with the implementation of minimally invasive surgeries.
Based on product, the market can be segmented into fundus cameras, retinal ultrasound imaging systems, refractors, slit lamps, perimetres, ophthalmoscopes, tonometre, optical coherence tomography (oct), and corneal topography systems.
On the basis of end-user, the market is categorised into hospitals, clinics, and ambulatory surgical centres. The regional markets for the ophthalmic diagnostic devices market can be divided into North America, Europe, the Asia Pacific, Latin America, the Middle East, and Africa.
The comprehensive EMR report provides an in-depth assessment of the market based on the Porter's five forces model along with giving a SWOT analysis. The report gives a detailed analysis of the following major ophthalmic diagnostic devices companies, covering their competitive landscape and the latest developments like mergers, acquisitions, investments, and expansion plans.
The optical coherence tomography (oct) segment accounts for a significant ophthalmic diagnostic devices market share on the account of better efficiency in the diagnosis of ocular disorders. With higher accuracy of diagnosis of the device type and rapid technological advancements in the product, the demand for optical coherence tomography (oct) is likely to increase in the market over the forecast period.
Moreover, optical coherence tomography (OCT) is a non-invasive imaging test. It employs light waves to take cross-section pictures of an individual’s retina. The surging awareness of glaucoma and cataracts is expected to propel the segment growth of optical coherence tomography (oct) across the globe.
Geographically, the North American region is expected to augment the ophthalmic diagnostic devices market development on account of the increasing awareness about ocular disorders. The growing adoption of ophthalmology diagnostic instruments, along with the surging prevalence of refractive error disorders, is expected to fuel the market growth of ophthalmic diagnostic devices across the region.
Meanwhile, the Asia Pacific region is expected to witness significant growth due to the increasing geriatric population, coupled with a high prevalence of cataract surgeries in countries like China, India, and Japan. The rising number of eye surgeries for ophthalmic conditions treatment in the region is expected to boost the ophthalmic diagnostic devices in the Asia Pacific region.
Read more about this report - REQUEST FREE SAMPLE COPY IN PDF
Nidek Co., Ltd. is a leading company that provides a huge range of equipment made for the treatment and diagnosis of glaucoma, and retinal diseases, among other vision-impairing afflictions. The company aims to help the field with products of unmatched service, value, and quality. It has been enlarging the boundaries of vision science since its establishment.
Quantel Medical was established in 1993 and the company manufactures, develops and markets advanced ultrasound and medical laser solutions. It provides a variety of Point of Care ultrasound that is perfectly constructed to meet the latest imaging demands in musculoskeletal medicine, general medicine, anaesthesia/resuscitation, and emergency medicine, among others.
Halma plc is a worldwide group of life-saving technology companies that was established in 1894. The group is a supplier of life protection products. Its product portfolio includes fire suppression, fire detection system, industrial access control, elevator safety system, therapeutic solutions, pressure management, life sciences, healthcare assessment, water and environmental monitoring, gas detection systems, and optical analysis.
Other market players include Coburn Technologies, Inc, and Bausch & Lomb Incorporated, among others.
REPORT FEATURES | DETAILS |
---|---|
Base Year | 2022 |
Historical Period | 2018-2022 |
Forecast Period | 2023-2028 |
Scope of the Report |
Historical and Forecast Trends, Industry Drivers and Constraints, Historical and Forecast Market Analysis by Segment:
|
Breakup by Product |
|
Breakup by Indication |
|
Breakup by End User |
|
Breakup by Region |
|
Market Dynamics |
|
Supplier Landscape |
|
Companies Covered |
|
*At Expert Market Research, we strive to always give you current and accurate information. The numbers depicted in the description are indicative and may differ from the actual numbers in the final EMR report.
1 Preface
1.1 Objectives of the Study
1.2 Key Assumptions
1.3 Report Coverage – Key Segmentation and Scope
1.4 Research Methodology
2 Executive Summary
3 Global Ophthalmic Diagnostic Devices Market Overview
3.1 Global Ophthalmic Diagnostic Devices Market Historical Value (2016-2022)
3.2 Global Ophthalmic Diagnostic Devices Market Forecast Value (2023-2031)
4 Global Ophthalmic Diagnostic Devices Market Landscape
4.1 Global Ophthalmic Diagnostic Devices Developers Landscape
4.1.1 Analysis by Year of Establishment
4.1.2 Analysis by Company Size
4.1.3 Analysis by Region
4.2 Global Ophthalmic Diagnostic Devices Product Landscape
4.2.1 Analysis by Product Type
4.2.2 Analysis by Indications
4.2.3 Analysis by End User
5 Global Ophthalmic Diagnostic Devices Market Dynamics
5.1 Market Drivers and Constraints
5.2 SWOT Analysis
5.3 Porter’s Five Forces Model
5.4 Key Demand Indicators
5.5 Key Price Indicators
5.6 Industry Events, Initiatives, and Trends
5.7 Value Chain Analysis
6 Global Ophthalmic Diagnostic Devices Market Segmentation
6.1 Global Ophthalmic Diagnostic Devices Market by Product Type
6.1.1 Market Overview
6.1.2 Fundus Cameras
6.1.3 Retinal Ultrasound Imaging Systems
6.1.4 Refractors
6.1.5 Slit Lamps
6.1.6 Perimetres
6.1.7 Ophthalmoscopes
6.1.8 Tonometre
6.1.9 Optical Coherence Tomography (OCT)
6.1.10 Corneal Topography Systems
6.1.11 Others
6.2 Global Ophthalmic Diagnostic Devices Market by Indication
6.2.1 Market Overview
6.2.2 Vision Care
6.2.3 Ophthalmic Wound care
6.2.4 Cataract Surgery
6.2.5 Oculoplastic
6.2.6 Others
6.3 Global Ophthalmic Diagnostic Devices Market by End User
6.3.1 Market Overview
6.3.2 Hospitals
6.3.3 Clinics
6.3.4 Optical Stores
6.3.5 Ambulatory Surgical Centers
6.3.6 Others
6.4 Global Ophthalmic Diagnostic Devices Market by Region
6.4.1 Market Overview
6.4.2 North America
6.4.3 Europe
6.4.4 Asia Pacific
6.4.5 Latin America
6.4.6 Middle East and Africa
7 North America Ophthalmic Diagnostic Devices Market
7.1 Market Share by Country
7.2 United States of America
7.3 Canada
8 Europe Ophthalmic Diagnostic Devices Market
8.1 Market Share by Country
8.2 United Kingdom
8.3 Germany
8.4 France
8.5 Italy
8.6 Others
9 Asia Pacific Ophthalmic Diagnostic Devices Market
9.1 Market Share by Country
9.2 China
9.3 Japan
9.4 India
9.5 ASEAN
9.6 Australia
9.7 Others
10 Latin America Ophthalmic Diagnostic Devices Market
10.1 Market Share by Country
10.2 Brazil
10.3 Argentina
10.4 Mexico
10.5 Others
11 Middle East and Africa Ophthalmic Diagnostic Devices Market
11.1 Market Share by Country
11.2 Saudi Arabia
11.3 United Arab Emirates
11.4 Nigeria
11.5 South Africa
11.6 Others
12 Patent Analysis
12.1 Analysis by Type of Patent
12.2 Analysis by Publication year
12.3 Analysis by Issuing Authority
12.4 Analysis by Patent Age
12.5 Analysis by CPC Analysis
12.6 Analysis by Patent Valuation
12.7 Analysis by Key Players
13 Grants Analysis
13.1 Analysis by year
13.2 Analysis by Amount Awarded
13.3 Analysis by Issuing Authority
13.4 Analysis by Grant Application
13.5 Analysis by Funding Institute
13.6 Analysis by NIH Departments
13.7 Analysis by Recipient Organization
14 Funding Analysis
14.1 Analysis by Funding Instances
14.2 Analysis by Type of Funding
14.3 Analysis by Funding Amount
14.4 Analysis by Leading Players
14.5 Analysis by Leading Investors
14.6 Analysis by Geography
15 Partnership and Collaborations Analysis
15.1 Analysis by Partnership Instances
15.2 Analysis by Type of Partnership
15.3 Analysis by Leading Players
15.4 Analysis by Geography
16 Regulatory Framework
16.1 Regulatory Overview
16.1.1 US FDA
16.1.2 EU EMA
16.1.3 INDIA CDSCO
16.1.4 JAPAN PMDA
16.1.5 Others
17 Supplier Landscape
17.1 EssilorLuxottica
17.1.1 Financial Analysis
17.1.2 Product Portfolio
17.1.3 Demographic Reach and Achievements
17.1.4 Mergers and Acquisitions
17.1.5 Certifications
17.2 Alcon Management S. A.
17.2.1 Financial Analysis
17.2.2 Product Portfolio
17.2.3 Demographic Reach and Achievements
17.2.4 Mergers and Acquisitions
17.2.5 Certifications
17.3 Johnson & Johnson Vision
17.3.1 Financial Analysis
17.3.2 Product Portfolio
17.3.3 Demographic Reach and Achievements
17.3.4 Mergers and Acquisitions
17.3.5 Certifications
17.4 HOYA Corporation
17.4.1 Financial Analysis
17.4.2 Product Portfolio
17.4.3 Demographic Reach and Achievements
17.4.4 Mergers and Acquisitions
17.4.5 Certifications
17.5 Bausch + Lomb
17.5.1 Financial Analysis
17.5.2 Product Portfolio
17.5.3 Demographic Reach and Achievements
17.5.4 Mergers and Acquisitions
17.5.5 Certifications
17.6 Zeiss
17.6.1 Financial Analysis
17.6.2 Product Portfolio
17.6.3 Demographic Reach and Achievements
17.6.4 Mergers and Acquisitions
17.6.5 Certifications
17.7 Neo Vision Foundation
17.7.1 Financial Analysis
17.7.2 Product Portfolio
17.7.3 Demographic Reach and Achievements
17.7.4 Mergers and Acquisitions
17.7.5 Certifications
17.8 Lumenis Be Ltd.
17.8.1 Financial Analysis
17.8.2 Product Portfolio
17.8.3 Demographic Reach and Achievements
17.8.4 Mergers and Acquisitions
17.8.5 Certifications
17.9 ClearLab
17.9.1 Financial Analysis
17.9.2 Product Portfolio
17.9.3 Demographic Reach and Achievements
17.9.4 Mergers and Acquisitions
17.9.5 Certifications
17.10 OPHTEC BV
17.10.1 Financial Analysis
17.10.2 Product Portfolio
17.10.3 Demographic Reach and Achievements
17.10.4 Mergers and Acquisitions
17.10.5 Certifications
17.11 HEINE Optotechnik GmbH & Co. KG
17.11.1 Financial Analysis
17.11.2 Product Portfolio
17.11.3 Demographic Reach and Achievements
17.11.4 Mergers and Acquisitions
17.11.5 Certifications
17.12 Topcon
17.12.1 Financial Analysis
17.12.2 Product Portfolio
17.12.3 Demographic Reach and Achievements
17.12.4 Mergers and Acquisitions
17.12.5 Certifications
17.13 Glaukos Corporation
17.13.1 Financial Analysis
17.13.2 Product Portfolio
17.13.3 Demographic Reach and Achievements
17.13.4 Mergers and Acquisitions
17.13.5 Certifications
17.14 Haag-Streit Group
17.14.1 Financial Analysis
17.14.2 Product Portfolio
17.14.3 Demographic Reach and Achievements
17.14.4 Mergers and Acquisitions
17.14.5 Certifications
17.15 NIDEK Co. Ltd.
17.15.1 Financial Analysis
17.15.2 Product Portfolio
17.15.3 Demographic Reach and Achievements
17.15.4 Mergers and Acquisitions
17.15.5 Certifications
17.16 STAAR Surgical
17.16.1 Financial Analysis
17.16.2 Product Portfolio
17.16.3 Demographic Reach and Achievements
17.16.4 Mergers and Acquisitions
17.16.5 Certifications
17.17 Ziemer Ophthalmic System
17.17.1 Financial Analysis
17.17.2 Product Portfolio
17.17.3 Demographic Reach and Achievements
17.17.4 Mergers and Acquisitions
17.17.5 Certifications
18 Global Ophthalmic Diagnostic Devices Market - Distribution Model (Additional Insight)
18.1 Overview
18.2 Potential Distributors
18.3 Key Parameters for Distribution Partner Assessment
19 Key Opinion Leaders (KOL) Insights (Additional Insight)
20 Company Competitiveness Analysis (Additional Insight)
20.1 Very Small Companies
20.2 Small Companies
20.3 Mid-Sized Companies
20.4 Large Companies
20.5 Very Large Companies
21 Payment Methods (Additional Insight)
21.1 Government Funded
21.2 Private Insurance
21.3 Out-of-Pocket
*Additional insights provided are customisable as per client requirements.
The global market for ophthalmic diagnostic devices attained a value of nearly USD 5.25 billion in 2022.
The market is assessed to grow at a CAGR of 4.90% during the forecast period of 2023-2028.
The market is estimated to witness healthy growth during the forecast period of 2023-2028 to attain a value of about USD 7 billion by 2028.
Ophthalmic devices are medical equipment created for surgery, vision correction, and diagnosis.
The speculum is the special instrument used for ophthalmic procedures.
The major market driver is the surging prevalence of refractive error disorders and the growing healthcare infrastructure.
The key ophthalmic diagnostic devices market trends include rapid advancement in technologies and the increase in awareness programs on eye disorders.
The various products of ophthalmic diagnostic devices include fundus cameras, retinal ultrasound imaging systems, refractors, slit lamps, perimetres, ophthalmoscopes, tonometres, optical coherence tomography (oct), and corneal topography systems.
The numerous end-users of ophthalmic diagnostic devices include hospitals, clinics, and ambulatory surgical centres.
The major players in the market are Nidek Co., Ltd., Quantel Medical, Halma plc, Coburn Technologies, Inc, and Bausch & Lomb Incorporated, among others.
Mini Report
Single User License
Five User License
Corporate License
Any Question? Speak With An Analyst
View A Sample
Did You Miss Anything, Ask Now
Right People
We are technically excellent, strategic, practical, experienced and efficient; our analysts are hand-picked based on having the right attributes to work successfully and execute projects based on your expectations.
Right Methodology
We leverage our cutting-edge technology, our access to trusted databases, and our knowledge of the current models used in the market to deliver you research solutions that are tailored to your needs and put you ahead of the curve.
Right Price
We deliver in-depth and superior quality research in prices that are reasonable, unmatchable, and shows our understanding of your resource structure. We, additionally, offer attractive discounts on our upcoming reports.
Right Support
Our team of expert analysts are at your beck and call to deliver you optimum results that are customised to meet your precise needs within the specified timeframe and help you form a better understanding of the industry.